The European Union just selected the project of Joint Master Degree coordinated by Paris Descartes University and entitled « Nanomedicine for drug delivery » (NANOMED) for co-funding under the Erasmus Mundus Joint Master Degrees program.
This curriculum gathers 4 European Universities Paris Descartes University, France (Coordinators: Prof. Karine Andrieux, Dr. Caroline Roques), Patras University, Greece (Prof. Sophia Antimisiaris), Pavia University, Italy (Prof. Carla Caramella, Dr. Christina Bonferoni), Angers University, France (Prof. Marie-Claire Venier, Dr. Emilie Roger, MINT laboratory).
This new curriculum aims at attracting outstanding students beyond the European borders and thus boost the attractiveness of the European Higher Education Area. The NANOMED curriculum will take advantage of the expertise of the four Partner Universities in the field of Nanomedicine combined to the competence of associate Partners (Universities, Private Companies) and invited speakers to provide top-level post-graduate courses in the field of Nanomedicine.
NANOMED is a 24-months Master’s course in English (4 semesters) offering a high quality and multidisciplinary education in the emerging field of Nanomedicine.
Nanomedicine is a revolutionary interdisciplinary science, which combines knowledge from Physics, Biology, Chemistry and Medicine to treat diseases of the human body. The consortium creates a curriculum that brings together the expertise of four Universities in their respective domains of Nanomedicine. Renowned experts in the field from academia and industry are yet involved in the pedagogical staff. The final goal is to achieve the qualification of young scientists with appropriate credentials in order to lead the related field, either in Industry or in Academia.
The curriculum provides both theoretical and practical knowledge for 3 semesters (Semesters 1, 2 and 3, 30 ECTS each) combined with an internship (Semester 4, 30 ECTS). Each student will receive a double/triple Master Degree corresponding to two or three diplomas issued by different Universities where the student would follow the semesters of courses.
Each participating student will have the opportunity to share a common background in Drug Delivery and a serious introduction in Nanomedicine. On the second year of master, the Advanced Nanomedicine part of the curriculum will correspond to the specialization of students by choosing a training option according to their professional project. In Angers, “Strategy of Nanomedicine Development for Clinical Application” is training professionals to manage innovative research project with skills in Nanomedicine transfer from research to clinical applications.
The first intake of students will join the program in September 2017, and thanks to EU funding, 12 students will be eligible for EU grants covering both the participation fees to the curriculum as well as their monthly expenses.
The students will be selected according to excellence criteria. Application requirements include the completion of a Bachelor’s degree in Pharmacy or Medicine or (under special provisions) in Chemistry, Biology, Biochemistry, Material Sciences or other adequate disciplines. English language proficiency is also required.